|
HSPA1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.611800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.282200E-02 |
| Normal-vs-Stage2 |
8.727700E-02 |
| Normal-vs-Stage3 |
9.310100E-02 |
| Normal-vs-Stage4 |
1.519400E-01 |
| Stage1-vs-Stage2 |
7.723400E-01 |
| Stage1-vs-Stage3 |
9.706400E-01 |
| Stage1-vs-Stage4 |
3.548600E-01 |
| Stage2-vs-Stage3 |
8.258000E-01 |
| Stage2-vs-Stage4 |
3.301600E-01 |
| Stage3-vs-Stage4 |
3.738800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.274100E-02 |
| Normal-vs-AfricanAmerican |
8.180200E-02 |
| Normal-vs-Asian |
3.116000E-01 |
| Caucasian-vs-AfricanAmerican |
5.634800E-01 |
| Caucasian-vs-Asian |
5.948000E-02 |
| AfricanAmerican-vs-Asian |
4.377600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.048100E-02 |
| Normal-vs-Female |
1.028800E-01 |
| Male-vs-Female |
1.920580E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.906300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.111160E-01 |
| Normal-vs-Age(61-80Yrs) |
8.433900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.348780E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.441200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.743200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.164000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.924800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.163600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.431800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.456000E-02 |
| Classical-VS-Follicular |
1.69520000037338E-07 |
| Classical-VS-Other |
5.567600E-02 |
| Classical-VS-Normal |
1.199790E-01 |
| Tall-VS-Follicular |
1.603600E-01 |
| Tall-VS-Other |
8.459200E-01 |
| Tall-VS-Normal |
7.450200E-02 |
| Follicular-VS-Other |
3.495000E-01 |
| Follicular-VS-Normal |
5.127900E-02 |
| Other-VS-Normal |
6.816000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.078570E-01 |
| Normal-vs-N1 |
8.421600E-02 |
| N0-vs-N1 |
3.696800E-01 |
|
|
